Cell and gene therapies allow for the creation of targeted life extending and potentially curative treatments for patients. But they have logistics challenges which limit their availability for patients.
In this video recorded for ISCT New Orleans 2021, Andrea Zobel, Senior Director, Personalized Supply Chain, examines the availability and logistics challenges of allogeneic and autologous therapies and the requirements to build a cryogenic logistics platform:
- Storage network
- Shipping capabilities
- Technology platform
Watch the recording below to learn more and discover World Courier's Advanced Therapies solutions here.